Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. It is the first cannabis company license to do business in the US by the DEA and federal government. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada.Tilray next earning report is Tuesday December 13, 2018.
If you decide to buy or trade tilray, please be advised that it is a very volatile stock. The gains and losses are substantial, so if trading one may want to buy a call or put vertical to limit risk. If investing, one must do their research to see if this investment is right for them. Tuesday is a big day for tilray due to their earnings. The stock peaked as high as $300 a share and declined from this price. Tuesdays report will test investors thoughts on the value of the company, relating to its stock price.